Literature DB >> 11527695

Long-term prognosis of gastric cancer in a European country: a population-based study in Florence (Italy). 10-year survival of cases diagnosed in 1985-1987.

A Barchielli1, A Amorosi, D Balzi, E Crocetti, G Nesi.   

Abstract

This paper analysed, in a population-based series of 1976 gastric cancers diagnosed in Florence (Italy), from 1985 to 1987, the relationship between prognostic variables (demographic, clinical and pathological) and 10-year survival rates. Gastric cancer was mostly detected in elderly patients (mean age: 70.5 years) and at advanced stages (i.e. approximately 50% of the patients could not undergo radical surgery). Ten-year observed survival was 12.1% (95% confidence interval (CI): 10.6-13.6%) for the whole series and 20.8% (95% CI: 18.3-23.3%) for resected cases; relative survival was, respectively, 20.9% (95% CI: 18.4-23.4%) and 32.0% (95% CI: 28.1-35.9%). Ten-year relative survival was 86% for stage IA (95% CI: 73-99%) and 67% for stage IB (95% CI: 52-82%). Multivariate analysis showed a significantly better prognosis in females and a significantly worse prognosis in patients aged 65 years or more (reference: < or = 59 years). In addition, an independent prognostic effect was observed for pT in the resected cases (reference: pT3; pT1: RR = 0.47, 95% CI: 0.34-0.64; pT2 = 0.71, 95% CI: 0.58-0.87; pT4: RR = 2.02, 95% CI: 1.49-2.75), pN (reference: pN0; pN1: RR = 2.13, 95% CI: 1.70-2.68; pN2-3: RR = 3.14, 95% CI: 2.42-4.07; pN+ no. nodes involved unspecified: RR = 4.26, 95% CI: 3.11-5.83) and surgical margin involvement (reference: not involved; involved: RR = 1.36, 95% CI: 1.08-1.72). In addition, the stage, after adjustment for age, gender and surgical margin involvement, showed a strong independent prognostic value (reference: stage II; IA: RR=0.37, 95% CI: 0.25-0.57; IB: RR=0.70, 95% CI: 0.50-0.98; IIIA: RR = 1.80, 95% CI: 1.40-2.33; IIIB: RR = 2.82, 95% CI: 2.14-3.72; IV: RR = 3.29, 95% CI: 2.36-4.59). In conclusion, on the basis of a large population-based series, our results confirm the prognostic effect on long-term gastric cancer survival of pathological and demographic variables. In addition, the study shows that Italy had a relatively good, long-term survival when diagnosis was performed at early stages. However, only a few cases were diagnosed at stages when cure by radical surgery is more likely (i.e. stage I accounted for approximately 20% of the resected cases and less than 10% of all incident cases).

Entities:  

Mesh:

Year:  2001        PMID: 11527695     DOI: 10.1016/s0959-8049(01)00179-4

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  14 in total

1.  Association of laryngeal cancer with previous gastric resection.

Authors:  Giovanni Cammarota; Jacopo Galli; Rossella Cianci; Eugenio De Corso; Vincenzo Pasceri; Domenico Palli; Giovanna Masala; Antonio Buffon; Antonio Gasbarrini; Giovanni Almadori; Gaetano Paludetti; Giovanni Gasbarrini; Maurizio Maurizi
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

2.  Prevalence of Helicobacter pylori infection and intestinal metaplasia in subjects who had undergone surgery for gastric adenocarcinoma in Northwest Italy.

Authors:  Giorgio Palestro; Rinaldo Pellicano; Gian Ruggero Fronda; Guido Valente; Marco De Giuli; Tito Soldati; Agostino Pugliese; Stefano Taraglio; Mauro Garino; Donata Campra; Miguel Angel Cutufia; Elena Margaria; Giancarlo Spinzi; Aldo Ferrara; Giorgio Marenco; Mario Rizzetto; Antonio Ponzetto
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

3.  The surgeon's expertise-outcome relationship in gastric cancer surgery.

Authors:  Wansik Yu; Young Kook Yun; Ilwoo Whang; Gyu Seok Choi
Journal:  Cancer Res Treat       Date:  2005-06-30       Impact factor: 4.679

4.  Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells.

Authors:  Hua Zhang; Jian Wu; Lin Meng; Cheng-Chao Shou
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

5.  Methionine-dependence and combination chemotherapy on human gastric cancer cells in vitro.

Authors:  Wei-Xin Cao; Jing-Min Ou; Xu-Feng Fei; Zheng-Gang Zhu; Hao-Ran Yin; Min Yan; Yan-Zhen Lin
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

6.  Prognostic factors and availability of D2 lymph node dissection for the patients with stage II gastric cancer: comparative analysis of subgroups in stage II.

Authors:  Joong-Min Park; Jong-Han Kim; Sung-Soo Park; Seung-Joo Kim; Young-Jae Mok; Chong-Suk Kim
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

7.  Factors correlated with peritoneal carcinomatosis and survival in patients with gastric cancer treated at a single institution in Brazil.

Authors:  Marcello F Fanelli; Milton J B Silva; Tadeu F de Paiva; Ludmilla T D Chinen; Andréa P G Guimarães; Daniel L Gimenes; Edilson D Pinheiro; José A Rinck; Ulisses R Nicolau; Solange M Sanches; Celso A L Melo; Aldo L A Dettino; Marcelo R S Cruz; Leila Maria M P de Melo; Maria N C Formiga; Vladmir C C de Lima
Journal:  Int J Clin Oncol       Date:  2009-08-25       Impact factor: 3.402

8.  Incidence and survival of stomach cancer in a high-risk population of Chile.

Authors:  Katy Heise; Enriqueta Bertran; Marcelo E Andia; Catterina Ferreccio
Journal:  World J Gastroenterol       Date:  2009-04-21       Impact factor: 5.742

9.  Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.

Authors:  Mansour-S Al-Moundhri; A Al-Shukaili; M Al-Nabhani; B Al-Bahrani; I-A Burney; A Rizivi; S-S Ganguly
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

10.  Survival of patients with stomach cancer in Changle city of China.

Authors:  Jun Tian; Xiao-Dong Wang; Zhen-Chun Chen
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.